158
Participants
Start Date
December 22, 2024
Primary Completion Date
June 1, 2025
Study Completion Date
June 20, 2025
Hydroxychloroquine Sulfate Tablets
the trial group use the hydroxychloroquine sulfate tablets (200mg/time, bid)
Placebo
the control group use the Placebo
RECRUITING
Department of Radiation Oncology, Chengdu
Xingchen Peng
OTHER